An annual programme to educate and support early stage medtech businesses.
About the programme
Led by Imperial College London, MedTech SuperConnector (MTSC) provides funding, training, advice and access to industry networks. The accelerator programme allows Early Career Researchers (ECRs) to connect with peers from other academic institutions and the networking opportunities they need to help fast-track the translation of their research discoveries.
We are a warm, open and encouraging community that offers researchers, academics and entrepreneurs the support and stimulation they need to turn their medtech ideas into businesses. Running annual accelerator programme intakes throughout the year, we’re always open to hearing from the next wave of medtech innovators.
We have supported over 34 ventures and 65+ ECRs to bring their innovative medical technologies closer to solving today’s biggest healthcare challenges. Covering innovations in skin health to handheld diagnostics – we support technologies ranging from devices to digital healthcare solutions.
ECRs supported from 8 HEIs
New medtech sector employment opportunities
Pilot Programmes & Partnerships signed
Technologies progressed towards clinical & user trials
Roliner by unhindr: Intelligent and adaptive prosthetic liner aims to keep amputees mobile Read more
Smart textiles to help people who have neurological conditions recover upper limb function Read more
A potential game-changer in the treatment of chronic respiratory conditions Read more
We offer a number of educational opportunities that we have developed for remote learning as well as face-to-face.
Funding of up to £50k is available for consumables, prototype development and access to specialist advice along with travel & conference fees.
As a programme participant, you’ll have access to domain experts, industry-specific support and networking opportunities.
Starting with a bootcamp, we run a series of masterclasses throughout each programme – covering topics such as intellectual property, regulatory strategy to market access and funding.
A salary replacement scheme is available for eligible postdocs released on to the programme. Venture funding is awarded directly to the lab. MedTech SuperConnector does not take IP.
Venture teams will have the opportunity to present their ideas and demonstrate the impact of their research to early stage investors and academic partners.
News and Events
In the second instalment of our case study series we are looking at Queen Mary University of London, an institution with a strong tradition of life science research and its own successful technology translation programme. Read more
The next cohort of MedTech SuperConnector will offer selected early-career researchers support to turn research into medical technology ventures Read more
We're delighted to announce that MTSC has received a further £3.44 million follow-on funding from Research England to continue our initiatives and widen the reach of our activities Read more